Frequently asked questions

Where will the trials be delivered?

Alongside similar studies in the Netherlands, we plan to rapidly deliver a clinical trial vaccinating older people in Devon and Warwickshire with the BCG vaccine to assess whether it has a protective effect. If this proves to be the case, the programme has the potential to be rolled out nationally and internationally.

What is the total amount of funding that’s required?

We are in urgent discussions with the UK Government who are very interested, however national health research resources in the UK are now over-stretched and so philanthropic support is vital to kick-start this trial. We urgently need your support to secure the £1.8 million required to deliver the trial in the UK. We have detailed trial protocols in place and ethical approval will be fast-tracked by the authorities so we will be ready to start the trial as soon as funding allows.

Is the trial open to anyone? How can I contact someone if I or a member of the team wish to take part?

Contact David Watson, Head of Alumni and Supporter Engagement at alumni@exeter.ac.uk

Where can I read more about the research behind the trial?

https://www.sciencemag.org/news/2020/03/can-century-old-tb-vaccine-steel-immune-system-against-new-coronavirus

If I want to speak to someone about my gift, how can I do so?

Contact David Watson, Head of Alumni and Supporter Engagement at alumni@exeter.ac.uk